HomeCompareGPOVF vs JNJ

GPOVF vs JNJ: Dividend Comparison 2026

GPOVF yields 1.16% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GPOVF wins by $7.47M in total portfolio value
10 years
GPOVF
GPOVF
● Live price
1.16%
Share price
$7.05
Annual div
$0.08
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.50M
Annual income
$6,430,673.17
Full GPOVF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GPOVF vs JNJ

📍 GPOVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGPOVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GPOVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GPOVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GPOVF
Annual income on $10K today (after 15% tax)
$98.26/yr
After 10yr DRIP, annual income (after tax)
$5,466,072.19/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, GPOVF beats the other by $5,462,086.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GPOVF + JNJ for your $10,000?

GPOVF: 50%JNJ: 50%
100% JNJ50/50100% GPOVF
Portfolio after 10yr
$3.76M
Annual income
$3,217,681.29/yr
Blended yield
85.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GPOVF
No analyst data
Altman Z
3.5
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GPOVF buys
0
JNJ buys
0
No recent congressional trades found for GPOVF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGPOVFJNJ
Forward yield1.16%2.13%
Annual dividend / share$0.08$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$7.50M$30.3K
Annual income after 10y$6,430,673.17$4,689.40
Total dividends collected$7.39M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GPOVF vs JNJ ($10,000, DRIP)

YearGPOVF PortfolioGPOVF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,931$231.21$10,592$272.30+$339.00GPOVF
2$12,169$472.40$11,289$357.73+$880.00GPOVF
3$14,004$982.97$12,123$472.89+$1.9KGPOVF
4$17,098$2,114.35$13,141$629.86+$4.0KGPOVF
5$23,120$4,825.40$14,408$846.81+$8.7KGPOVF
6$36,935$12,196.23$16,021$1,151.60+$20.9KGPOVF
7$75,938$36,417.92$18,122$1,588.22+$57.8KGPOVF
8$221,208$139,953.54$20,930$2,228.20+$200.3KGPOVF
9$998,716$762,023.71$24,792$3,191.91+$973.9KGPOVF
10$7,499,299$6,430,673.17$30,274$4,689.40+$7.47MGPOVF

GPOVF vs JNJ: Complete Analysis 2026

GPOVFStock

Grupo Carso, S.A.B. de C.V., together with its subsidiaries, engages in the commercial, industrial, infrastructure and construction, and energy sectors. It operates through Commercial and Consumer, Industrial and Manufacturing, Infrastructure and Construction, and Energy divisions. The company's Commercial and Consumption division operates department stores and boutiques, gift shops, restaurants, coffee shops, electronics, and technology and games stores under the Sears, Sanborns, iShop, Mixup, Claro Shop, and Saks Fifth Avenue brands. The company's Industrial and Manufacturing division provides cables, such as energy, telecommunication, electronic, coaxial, and fiber optics for application in mining, automotive, and other; electric harnesses for automotive industry; precision steel tubing; power transformers; and alternate energy. It serves customers under the Condumex, Latincasa, Vinanel, Condulac, IEM, Precitubo, Sitcom, Microm, Sinergia, Equiter, and Logtec brands. The company's Infrastructure and Construction division constructs roads, tunnels, water treatment plants, and general infrastructure works; oil and geothermic well drilling and drilling services; and oil platforms and equipment for chemical and petroleum industries. It also constructs commercial centers, industrial plants, and office building and houses; and telecommunication facilities, gas pipelines, and aqueducts under the CICSA, Swecomex, Bronco Drilling, Cilsa, GSM, PC Construcciones, and Urvitec brands. The company's Energy division engages in the gas transportation services; and exploration and production of oil, gas, and other hydrocarbons, as well as explores geothermal energy under the Carso Energy, Carso Oil & Gas, and Carso Electric brands. It serves customers in Mexico; Central America, South America, and the Caribbean; the United States; Europe; and internationally. Grupo Carso, S.A.B. de C.V. is incorporated in 1980 and is headquartered in Mexico City, Mexico.

Full GPOVF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GPOVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GPOVF vs SCHDGPOVF vs JEPIGPOVF vs OGPOVF vs KOGPOVF vs MAINGPOVF vs ABBVGPOVF vs MRKGPOVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.